Recombinant Human CD367/CLEC4A Protein，His

CD367, also known as CLEC4A, is a type of C-type lectin receptor that plays a significant role in the immune system, particularly in the recognition and uptake of pathogens. It is predominantly expressed on dendritic cells and other antigen-presenting cells, where it functions to modulate immune responses through its ability to bind to specific carbohydrate structures on the surface of microorganisms and tumor cells. Research on CD367/CLEC4A has garnered attention due to its potential implications in various diseases, including infections, cancer, and autoimmune disorders. By studying the recombinant forms of CD367, scientists aim to better understand its ligand-binding properties and signaling mechanisms, which could lead to the development of novel therapeutic strategies. The elucidation of CD367's role in immune regulation might provide insights into enhancing vaccine efficacy and designing targeted therapies to manipulate immune responses for better clinical outcomes. Furthermore, as a target for monoclonal antibodies, CD367 could offer new avenues for immune checkpoint inhibition, thereby broadening the scope of immunotherapy. Overall, the study of CD367/CLEC4A recombinant proteins is pivotal in advancing our understanding of immune dynamics, paving the way for innovative diagnostics and therapeutics in immunology.